Halozyme Inc - Company & Market Research Reports

Halozyme was founded in 1998, the headquarters are located in San Diego, California. It is a biotechnology company that innovates cancer therapies that target the tumor microenvironment. PEGPH20, their main proprietary programme applies a unique approach to targeting solid tumors it may help make existing treatments more effective by allowing therapies to reach the tumor. Halozyme has teamed up with many partnering companies such as: Roche, Pfizer, Janssen, Baxalta, AbbVie and Lilly for the NHANZE™ drug delivery technology platform.

From
From
From
From
From
From
From
From
From
From
Contact Dermatitis - Pipeline Insight, 2018 - Product Thumbnail Image

Contact Dermatitis - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
From
Pancreatic Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Pancreatic Cancer - Pipeline Review, H1 2018

  • Drug Pipelines
  • 2509 Pages
From
From
From
From
From
Loading Indicator
adroll